Literature DB >> 13479153

The hypersensitivity reactions to para-aminosalicylic acid (P.A.S.).

S CARNE.   

Abstract

Entities:  

Keywords:  ALLERGY; PARA-AMINOSALICYLIC ACID/injurious effects

Mesh:

Substances:

Year:  1957        PMID: 13479153      PMCID: PMC2012167          DOI: 10.1136/adc.32.165.446

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  16 in total

1.  Hyperthyroidism developing during P.A.S. therapy.

Authors:  S TANDHANAND; R BURI
Journal:  Br Med J       Date:  1956-08-04

2.  Severe paraaminosalicylic acid hypersensitivity; blood and lymph node studies.

Authors:  W CANNEMEYER; J R THOMPSON; M R LICHTENSTEIN
Journal:  Blood       Date:  1955-01       Impact factor: 22.113

3.  Severe para-aminosalicylic acid hypersensitivity simulating mononucleosis or hepatitis.

Authors:  M R LICHTENSTEIN; W CANNEMEYER
Journal:  J Am Med Assoc       Date:  1953-06-13

4.  Treatment of primary pulmonary tuberculosis with P.A.S.

Authors:  R M TODD
Journal:  Br Med J       Date:  1953-06-06

5.  A case of myxoedema developing during p-aminosalicylic acid therapy.

Authors:  G M KOMROWER
Journal:  Br Med J       Date:  1951-11-17

6.  Pulmonary eosinophilia.

Authors:  J W CROFTON; J L LIVINGSTONE; N C OSWALD; A T M ROBERTS
Journal:  Thorax       Date:  1952-03       Impact factor: 9.139

7.  [Manifestations of hypersensitivity to PAS].

Authors:  J C GERRITS
Journal:  Geneeskd Gids       Date:  1951-05-03

8.  [Severe allergic reactions caused by paraminosalicylic acid].

Authors:  W KNIEST
Journal:  Dtsch Med Wochenschr       Date:  1952-05-23       Impact factor: 0.628

9.  Acquired hypersensitivity to sodium P.A.S. streptomycin, and penicillin.

Authors:  B JEFFERY; P BORRIE; N MACDONALD
Journal:  Br Med J       Date:  1952-09-20

10.  Acquired idiosyncrasy to sodium p-aminosalicylate.

Authors:  J CUTHBERT
Journal:  Lancet       Date:  1950-08-05       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.